ATE321867T1 - Zusammensetzungen und methoden zur verwendung von dna polymerasen - Google Patents

Zusammensetzungen und methoden zur verwendung von dna polymerasen

Info

Publication number
ATE321867T1
ATE321867T1 AT00973960T AT00973960T ATE321867T1 AT E321867 T1 ATE321867 T1 AT E321867T1 AT 00973960 T AT00973960 T AT 00973960T AT 00973960 T AT00973960 T AT 00973960T AT E321867 T1 ATE321867 T1 AT E321867T1
Authority
AT
Austria
Prior art keywords
compositions
methods
polymerase
dna polymerases
mutant
Prior art date
Application number
AT00973960T
Other languages
English (en)
Inventor
Joseph A Sorge
Holly H Hogrefe
Connie J Hansen
Original Assignee
Stratagene California
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Stratagene California filed Critical Stratagene California
Application granted granted Critical
Publication of ATE321867T1 publication Critical patent/ATE321867T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/12—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
    • C12N9/1241—Nucleotidyltransferases (2.7.7)
    • C12N9/1252—DNA-directed DNA polymerase (2.7.7.7), i.e. DNA replicase
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y10/00—Nanotechnology for information processing, storage or transmission, e.g. quantum computing or single electron logic

Landscapes

  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nanotechnology (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medical Informatics (AREA)
  • Biophysics (AREA)
  • Biomedical Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Mathematical Physics (AREA)
  • Theoretical Computer Science (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
AT00973960T 1999-10-29 2000-10-27 Zusammensetzungen und methoden zur verwendung von dna polymerasen ATE321867T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US16260099P 1999-10-29 1999-10-29

Publications (1)

Publication Number Publication Date
ATE321867T1 true ATE321867T1 (de) 2006-04-15

Family

ID=22586340

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00973960T ATE321867T1 (de) 1999-10-29 2000-10-27 Zusammensetzungen und methoden zur verwendung von dna polymerasen

Country Status (7)

Country Link
US (2) US6946273B1 (de)
EP (1) EP1226255B1 (de)
JP (1) JP4949585B2 (de)
AT (1) ATE321867T1 (de)
AU (1) AU1239901A (de)
DE (1) DE60027040T2 (de)
WO (1) WO2001032887A1 (de)

Families Citing this family (108)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030228616A1 (en) * 1999-10-29 2003-12-11 Stratagene DNA polymerase mutants with reverse transcriptase activity
US20040009486A1 (en) * 1999-10-29 2004-01-15 Sorge Joseph A. Compositions and methods utilizing DNA polymerases
US20050123940A1 (en) * 1999-10-29 2005-06-09 Stratagene California Compositions and methods for synthesizing cDNA
US8268605B2 (en) 1999-10-29 2012-09-18 Agilent Technologies, Inc. Compositions and methods utilizing DNA polymerases
US20030180741A1 (en) 2001-12-21 2003-09-25 Holly Hogrefe High fidelity DNA polymerase compositions and uses therefor
US6803201B2 (en) 2002-01-24 2004-10-12 Stratagene Compositions and methods for polynucleotide sequence determination
AU2003301590A1 (en) * 2002-10-25 2004-05-13 Stratagene California Dna polymerases with reduced base analog detection activity
US8283148B2 (en) 2002-10-25 2012-10-09 Agilent Technologies, Inc. DNA polymerase compositions for quantitative PCR and methods thereof
US7960157B2 (en) 2002-12-20 2011-06-14 Agilent Technologies, Inc. DNA polymerase blends and uses thereof
AU2004225520A1 (en) 2003-03-25 2004-10-14 Stratagene DNA polymerase fusions and uses thereof
GB0321306D0 (en) 2003-09-11 2003-10-15 Solexa Ltd Modified polymerases for improved incorporation of nucleotide analogues
GB0324456D0 (en) * 2003-10-20 2003-11-19 Isis Innovation Parallel DNA sequencing methods
US20100216153A1 (en) 2004-02-27 2010-08-26 Helicos Biosciences Corporation Methods for detecting fetal nucleic acids and diagnosing fetal abnormalities
WO2005118815A1 (ja) 2004-06-04 2005-12-15 Takara Bio Inc. Dnaポリメラーゼ活性を有するポリペプチド
JP4990886B2 (ja) 2005-05-10 2012-08-01 ソレックサ リミテッド 改良ポリメラーゼ
KR100757280B1 (ko) 2005-11-01 2007-09-11 한국해양연구원 고호열성 신균주 kctc 10859bp 및 이로부터 생산되는고호열성 아밀라아제
EP1914303A1 (de) * 2006-10-09 2008-04-23 Qiagen GmbH Thermus eggertssonii DNA Polymerasen
KR100777230B1 (ko) * 2006-11-30 2007-11-28 한국해양연구원 써모코커스 유래 돌연변이 dna 중합효소들 및 그의유전자들
EP2097523B1 (de) * 2006-12-29 2014-10-29 Agilent Technologies, Inc. Zusammensetzungen und verfahren unter verwendung von gespaltenen polymerasen
US20090137405A1 (en) * 2007-11-16 2009-05-28 Christopher Bowman Detection of nucleic acid biomarkers using polymerization-based amplification
US7682809B2 (en) 2008-01-11 2010-03-23 Agilent Technologies, Inc. Direct ATP release sequencing
US10227641B2 (en) 2008-04-30 2019-03-12 Integrated Dna Technologies, Inc. RNase H-based assays utilizing modified RNA monomers
EP3150727B1 (de) 2008-04-30 2019-07-10 Integrated DNA Technologies Inc. Rnase-h-basierte assays unter verwendung von modifizierten rna monomeren
WO2010062776A2 (en) 2008-11-03 2010-06-03 Kapabiosystems Chimeric dna polymerases
US8628762B2 (en) 2008-12-10 2014-01-14 Icahn School Of Medicine At Mount Sinai T-helper cell type 17 lineage-specific adjuvants, compositions and methods
WO2011032097A1 (en) 2009-09-14 2011-03-17 Mount Sinai School Of Medicine Methods for characterizing antibody binding affinity and epitope diversity in food allergy
US8715987B2 (en) 2011-05-02 2014-05-06 New England Biolabs, Inc. Solubilized phospholipids for stabilizing nucleic acid polymerases
EP2707481B1 (de) 2011-05-11 2016-07-13 New England Biolabs, Inc. Dna-polymerasevarianten mit verminderter exonukleaseaktivität und ihre anwendung
US8921044B2 (en) 2011-05-11 2014-12-30 New England Biolabs, Inc. DNA polymerase variants with reduced exonuclease activity and uses thereof
WO2012177792A2 (en) 2011-06-24 2012-12-27 Sequenom, Inc. Methods and processes for non-invasive assessment of a genetic variation
US9984198B2 (en) 2011-10-06 2018-05-29 Sequenom, Inc. Reducing sequence read count error in assessment of complex genetic variations
US10424394B2 (en) 2011-10-06 2019-09-24 Sequenom, Inc. Methods and processes for non-invasive assessment of genetic variations
WO2013052913A2 (en) 2011-10-06 2013-04-11 Sequenom, Inc. Methods and processes for non-invasive assessment of genetic variations
EP2764458B1 (de) 2011-10-06 2021-04-07 Sequenom, Inc. Verfahren und prozesse zur nicht-invasiven beurteilung genetischer variationen
US10196681B2 (en) 2011-10-06 2019-02-05 Sequenom, Inc. Methods and processes for non-invasive assessment of genetic variations
ES2929923T3 (es) 2012-01-20 2022-12-02 Sequenom Inc Procesos de diagnóstico que condicionan las condiciones experimentales
US9920361B2 (en) 2012-05-21 2018-03-20 Sequenom, Inc. Methods and compositions for analyzing nucleic acid
US10504613B2 (en) 2012-12-20 2019-12-10 Sequenom, Inc. Methods and processes for non-invasive assessment of genetic variations
US9951378B2 (en) 2012-06-14 2018-04-24 Life Technologies Corporation Compositions, methods and kits for real time polymerase chain reaction (PCR)
US10497461B2 (en) 2012-06-22 2019-12-03 Sequenom, Inc. Methods and processes for non-invasive assessment of genetic variations
JP6478446B2 (ja) 2012-09-28 2019-03-06 東洋紡株式会社 改変された耐熱性dnaポリメラーゼ
US10482994B2 (en) 2012-10-04 2019-11-19 Sequenom, Inc. Methods and processes for non-invasive assessment of genetic variations
US20130309666A1 (en) 2013-01-25 2013-11-21 Sequenom, Inc. Methods and processes for non-invasive assessment of genetic variations
EP4187543A1 (de) 2013-04-03 2023-05-31 Sequenom, Inc. Verfahren und prozesse zur nichtinvasiven beurteilung genetischer variationen
AU2014268377B2 (en) 2013-05-24 2020-10-08 Sequenom, Inc. Methods and processes for non-invasive assessment of genetic variations
DK3011051T3 (en) 2013-06-21 2019-04-23 Sequenom Inc Method for non-invasive evaluation of genetic variations
AU2014306271A1 (en) 2013-08-08 2016-03-24 The Scripps Research Institute A method for the site-specific enzymatic labelling of nucleic acids in vitro by incorporation of unnatural nucleotides
US10964409B2 (en) 2013-10-04 2021-03-30 Sequenom, Inc. Methods and processes for non-invasive assessment of genetic variations
JP6680680B2 (ja) 2013-10-07 2020-04-15 セクエノム, インコーポレイテッド 染色体変化の非侵襲性評価のための方法およびプロセス
AU2014348323B2 (en) 2013-11-14 2020-09-24 Integrated Dna Technologies, Inc. DNA polymerase mutants having enhanced template discrimination activity
EP3129493B1 (de) 2014-04-09 2021-07-07 The Scripps Research Institute Import von unnatürlichen oder modifizierten nukleosid-triphosphaten in zellen mittels nukleinsäure-triphosphattransportern
US11783911B2 (en) 2014-07-30 2023-10-10 Sequenom, Inc Methods and processes for non-invasive assessment of genetic variations
US10329545B2 (en) 2014-11-14 2019-06-25 Illumina, Inc. Polymerases
EP3347461A1 (de) * 2015-09-09 2018-07-18 Qiagen GmbH Polymeraseenzym
WO2017106767A1 (en) 2015-12-18 2017-06-22 The Scripps Research Institute Production of unnatural nucleotides using a crispr/cas9 system
LT3402880T (lt) 2016-01-15 2024-03-12 Thermo Fisher Scientific Baltics Uab Termofiliniai dnr polimerazės mutantai
WO2017148861A1 (en) 2016-02-29 2017-09-08 Genia Technologies, Inc. Exonuclease deficient polymerases
WO2017201315A1 (en) 2016-05-18 2017-11-23 Roche Sequencing Solutions, Inc. Quantitative real time pcr amplification using an electrowetting-based device
WO2017210469A2 (en) 2016-06-01 2017-12-07 F. Hoffman-La Roche Ag Immuno-pete
EP3475295B1 (de) 2016-06-24 2022-08-10 The Scripps Research Institute Neuartiger nukleosid-triphosphat-transporter und verwendungen davon
ES2855748T3 (es) 2016-07-12 2021-09-24 Hoffmann La Roche Enriquecimiento de diana de extensión de cebador
US11200963B2 (en) 2016-07-27 2021-12-14 Sequenom, Inc. Genetic copy number alteration classifications
CA3207879C (en) 2017-01-24 2026-06-16 Sequenom, Inc. Methods and processes for assessment of genetic variations
EP3580351A1 (de) * 2017-02-13 2019-12-18 Qiagen Sciences, LLC Polymeraseenzym aus 9°n
US12297491B2 (en) 2017-03-08 2025-05-13 Roche Sequencing Solutions, Inc. Primer extension target enrichment and improvements thereto including simultaneous enrichment of DNA and RNA
JP6970205B2 (ja) 2017-03-08 2021-11-24 エフ.ホフマン−ラ ロシュ アーゲーF. Hoffmann−La Roche Aktiengesellschaft Dnaおよびrnaの同時濃縮を含むプライマー伸長標的濃縮およびそれに対する向上
EP3998350B1 (de) 2017-03-17 2025-05-07 Sequenom, Inc. Verfahren und vorgänge zur beurteilung von genetischem mosaizismus
US10883092B2 (en) * 2017-04-18 2021-01-05 Mgi Tech Co., Ltd. Phi29 DNA polymerase and encoding gene and application thereof
US11618891B2 (en) 2017-06-26 2023-04-04 Thermo Fisher Scientific Baltics Uab Thermophilic DNA polymerase mutants
TWI821192B (zh) 2017-07-11 2023-11-11 美商新索思股份有限公司 非天然核苷酸之導入及其方法
WO2019014262A1 (en) 2017-07-11 2019-01-17 The Scripps Research Institute INCORPORATION OF NON-NATURAL NUCLEOTIDES AND METHODS OF IN VIVO USE THEREOF
IL321812A (en) 2017-08-03 2025-08-01 Synthorx Inc Cytokine complexes for the treatment of autoimmune diseases
JP7429642B2 (ja) 2017-12-29 2024-02-08 ザ スクリプス リサーチ インスティテュート 非天然塩基対組成物および使用の方法
JP7515413B2 (ja) 2018-10-31 2024-07-12 イラミーナ インコーポレーテッド ポリメラーゼ、組成物、および使用方法
EP3891275A2 (de) 2018-12-05 2021-10-13 Illumina, Inc. Polymerasen, zusammensetzungen und verfahren zur verwendung
MA54952A (fr) 2019-02-06 2022-05-11 Synthorx Inc Conjugués d'il-2 et méthodes d'utilisation de ceux-ci
WO2020252262A1 (en) 2019-06-14 2020-12-17 The Scripps Research Institute Reagents and methods for replication, transcription, and translation in semi-synthetic organisms
EP4017977A1 (de) 2019-08-19 2022-06-29 F. Hoffmann-La Roche AG Einzelröhrchenvorbereitung von dna und rna zur sequenzierung
EP4031679A1 (de) 2019-09-20 2022-07-27 F. Hoffmann-La Roche AG Profilierung eines immunrepertoires durch primer-extension-target-anreicherung
US20210139867A1 (en) 2019-11-08 2021-05-13 Omniome, Inc. Engineered polymerases for improved sequencing by binding
US11591629B2 (en) * 2019-12-23 2023-02-28 Cheng-Yao Chen Method and kit for template-independent nucleic acid synthesis
CN115956128B (zh) 2020-07-08 2026-03-27 豪夫迈·罗氏有限公司 在下一代测序文库的靶捕获过程中使用毒性引物对非靶文库分子进行靶向消耗
US12378596B2 (en) 2020-12-03 2025-08-05 Roche Sequencing Solutions, Inc. Whole transcriptome analysis in single cells
JP7900392B2 (ja) 2020-12-24 2026-08-04 インテグレイテツド・デイー・エヌ・エイ・テクノロジーズ・インコーポレイテツド 高忠実度DNAポリメラーゼによるrhPCRベース増幅産物シーケンシングにおいて、プライマー二量体及びオフターゲット増幅を低減するRNアーゼH2突然変異体
CN112779238B (zh) * 2020-12-28 2024-01-30 广州达安基因股份有限公司 用于丙肝病毒检测的dna聚合酶混合物
WO2022174898A1 (en) 2021-02-18 2022-08-25 F. Hoffmann-La Roche Ag Structure to prevent threading of nucleic acid templates through a nanopore during sequencing
WO2022197589A1 (en) 2021-03-15 2022-09-22 President And Fellows Of Harvard College Methods for in situ sequencing
WO2022194764A1 (en) 2021-03-15 2022-09-22 F. Hoffmann-La Roche Ag Targeted next-generation sequencing via anchored primer extension
EP4314337A1 (de) 2021-04-01 2024-02-07 F. Hoffmann-La Roche AG Immunzellenzählung von sars-cov-2-patienten auf der basis von immunrepertoiresequenzierung
JP2024522795A (ja) * 2021-06-18 2024-06-21 エレメント バイオサイエンシズ,インコーポレイティド 操作されたポリメラーゼ
US12077789B2 (en) 2021-08-14 2024-09-03 Illumina, Inc. Polymerases, compositions, and methods of use
TWI869710B (zh) * 2021-09-29 2025-01-11 呈堯 陳 用於無模板rna合成的核酸聚合酶變體、試劑套組及方法
CN114015672B (zh) * 2021-12-06 2022-05-31 江南大学 一种Pfu DNA聚合酶
US12006518B2 (en) * 2022-02-18 2024-06-11 Element Biosciences, Inc. Engineered polymerases with reduced sequence-specific errors
EP4547839A1 (de) 2022-06-30 2025-05-07 Kapa Biosystems, Inc. Steuerung der tagmentationssequenzierungsbibliothekseinsatzgrösse unter verwendung histonähnlicher proteine in der archae
CN121241132A (zh) * 2023-06-02 2025-12-30 武汉华大智造科技有限公司 用于测序的dna聚合酶突变体
JP2026524816A (ja) 2023-06-14 2026-07-24 エフ. ホフマン-ラ ロシュ アーゲー 加速された5-ホルミルシトシンのマーキングおよび核酸メチル化シーケンシングにおける使用
EP4750913A1 (de) 2023-07-26 2026-06-03 Caribou Biosciences, Inc. In-vitro-validierungsverfahren für auf cd19 abzielende zelltherapien
WO2025193609A1 (en) 2024-03-11 2025-09-18 Caribou Biosciences, Inc. Methods and compositions for cost-effective assessment of nucleic acid transcripts and isoforms in cells
TW202603156A (zh) 2024-03-25 2026-01-16 美商欣爍克斯公司 用於生產多肽之合成tRNA合成酶及包含合成分子的細胞
WO2025210056A1 (en) 2024-04-03 2025-10-09 Roche Sequencing Solutions, Inc. In vitro amplification of dna methylation patterns
WO2025240460A2 (en) 2024-05-14 2025-11-20 Roche Molecular Systems, Inc. Assay for detection of mutations conferring resistance to treatment with an immunotherapeutic agent
WO2026082489A1 (en) 2024-10-18 2026-04-23 F. Hoffmann-La Roche Ag Universal pcr to boost molecule recovery in cell free dna library preparation and target enrichment workflows
WO2026087220A1 (en) 2024-10-22 2026-04-30 F. Hoffmann-La Roche Ag Preparation of dna libraries for next generation sequencing using y-adapters modified with phosphorothioate bonds
WO2026093331A1 (en) 2024-10-28 2026-05-07 F. Hoffmann-La Roche Ag Hairpin adapter constructs and primers to generate next-generation sequencing library molecules
WO2026099278A1 (en) 2024-11-08 2026-05-15 F. Hoffmann-La Roche Ag Normalizing and pooling of pcr-free sequencing libraries
WO2026128440A2 (en) 2024-12-11 2026-06-18 Roche Molecular Systems, Inc. Tandem isothermal amplification and polymerase chain reaction
WO2026151663A1 (en) 2025-01-07 2026-07-16 Kapa Biosystems, Inc. Selective rna tagging methods of total nucleic samples for sequencing applications

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5674679A (en) 1991-09-27 1997-10-07 Amersham Life Science, Inc. DNA cycle sequencing
US5547859A (en) * 1993-08-02 1996-08-20 Goodman; Myron F. Chain-terminating nucleotides for DNA sequencing methods
US5614365A (en) * 1994-10-17 1997-03-25 President & Fellow Of Harvard College DNA polymerase having modified nucleotide binding site for DNA sequencing
DE69400567T2 (de) 1994-10-17 1997-02-06 President And Fellows Of Harvard College, Cambridge, Mass. DNS Polymerase mit veränderter Nukleotid-Bindungstelle
CA2222744C (en) * 1995-05-31 2008-03-25 Amersham Life Science, Inc. Thermostable dna polymerases
CA2251643A1 (en) * 1996-04-15 1997-10-23 University Of Alberta Synthesis of fluorophore-labeled dna
US5882904A (en) 1997-08-04 1999-03-16 Amersham Pharmacia Biotech Inc. Thermococcus barossii DNA polymerase mutants

Also Published As

Publication number Publication date
DE60027040D1 (de) 2006-05-18
WO2001032887A1 (en) 2001-05-10
DE60027040T2 (de) 2006-11-23
AU1239901A (en) 2001-05-14
US6946273B1 (en) 2005-09-20
US20050158730A1 (en) 2005-07-21
JP4949585B2 (ja) 2012-06-13
EP1226255A1 (de) 2002-07-31
EP1226255B1 (de) 2006-03-29
JP2004500052A (ja) 2004-01-08

Similar Documents

Publication Publication Date Title
DE60027040D1 (de) Zusammensetzungen und methoden zur verwendung von dna polymerasen
WO2003054139A3 (en) Compositions and methods utilizing dna polymerases
BG100188A (bg) Ензими за секвениране на днк
ATE302279T1 (de) Kälteempfindliche dna-polymerasemutanten
EP2272952B8 (de) Thermostabiler oder thermoactiver DNA-polymerase mit abgeschwächter 3'-5' Exonukleaseaktivität
WO1995014782A3 (en) A modified thermo resistant dna polymerase
DE69534855D1 (de) Enzymaktive dna moleküle
WO2001061015A3 (de) Thermostable chimeric nucleic acid polymerases and uses thereof
WO2001051006A3 (en) Cardiac-cell specific enhancer elements and uses thereof
ATE181106T1 (de) Mutationen in der 5'-3'-exonukleaseaktivität thermostabiler dna-polymerasen
DE60110564D1 (en) Rna polymerase mutanten mit erhöhter thermostabilität
ATE380883T1 (de) Direkte multiplex charakterisierung von genomischer dna
MXPA02012256A (es) Proteinas v de morbillivirus modificados.
ATE248917T1 (de) Klonierte dna polymerasen aus thermotoga neapolitana und resultierende mutanten
WO2002086088A3 (en) Polymerases with charge-switch activity and methods of generating such polymerases
ES2162132T3 (es) Polimerasa de adn termoestable procedente de thermoanaerobacter thermohydrosulfuricus y enzimas mutantes, de actividad exonucleasa suprimida asi obtenidos.
DE69133629D1 (de) nssystem zur Bestimmung von genetischen Krankheiten
WO2004022770A3 (en) Compositions and methods for synthesizing nucleic acids
WO2001025483A3 (en) Compositions for dna amplification, synthesis, and mutagenesis
DE60229050D1 (de) Verfahren zur herstellung von ascorbinsäurezwischenprodukten in wirtszellen
ATE371022T1 (de) Fy7 polymerase
WO2002020735A3 (en) Enzymes having high temperature polymerase activity and methods of use thereof
ATE277171T1 (de) Ikk-alpha proteine, nukleinsäuren und verfahren
AU1070002A (en) Materials and methods relating to nucleic acid amplification and profiling
EP0810288A3 (de) Neue DNA-Polymerase mit 3'-5' Proofreading Exonuklease Atkivität zur Korrekturlesung

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties